Concepedia

Laurie Connor

LC

Statistics

Publications

4

Citations

90

H-Index

4

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Laurie Connor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in vaccine safety, vaccination, and virology.

Top concepts

Publications per year

2016–2023

4

Publications

4

Women’s experience of maternal morbidity: a qualitative analysis

Sarah Meaney, Jennifer E. Lutomski, Laurie Connor et al. · BMC Pregnancy and Childbirth · 2016 · 29 citations · Full text

Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men

Anna R. Giuliano, Timothy Wilkin, Oliver Bautista et al. · Contemporary Clinical Trials · 2021 · 28 citations

, , +10

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Randall Severance, Howard Schwartz, Ron Dagan et al. · Human Vaccines & Immunotherapeutics · 2021 · 19 citations · Full text

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Andrew W. Lee, Ken Liu, Édouard Lhomme et al. · Clinical Infectious Diseases · 2023 · 14 citations · Full text

Rows per page

1–4 of 4